Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adenocarcinoma of Lung × enzalutamide × Sarcoma × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Sarcoma 1 Genitourinary 1 Gastrointestinal 1 Breast 1

Conditions

Prostatic Neoplasms 1 Liposarcoma 1 Colorectal Neoplasms 1 Breast Neoplasms 1 Adenocarcinoma of Lung 1

Interventions

sintilimab 1 enzalutamide 1 Pemetrexed 1 Midazolam 1 Letrozole 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Fulvestrant 1 Cisplatin 1 Carboplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04557449 2025-10-01

CDK4i

Pfizer

Phase 2 Active not recruiting

BreastGastrointestinalGenitourinarySarcomaThoracic

Adenocarcinoma of Lung, Breast Neoplasms, Liposarcoma, Prostatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡